×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| INVESCO India Gold Exchange Tr | NA | NA | NA | NA | 0 | |
| MOTILAL OSWAL MOST SHARES NASD | NA | NA | NA | NA | 0 | |
| Indegene Limited | 7829.0 | 1164.0 | 7608.0 | 4.82 | 13,481 | 31.0 |
| Sanofi Consumer Healthcare Ind | 2265.0 | 607.0 | 2209.0 | 26.36 | 11974 | 60.5 |
| Le Travenues Technology Limite | 3214.33 | 189.43 | 3144.72 | 0.48 | 11431 | 179.0 |
Indegene Limited has established itself in the None sector, offering a range of products and services that cater to its market. With a strong presence in its field, the company is committed to growth and innovation in the industry.
| Metrics | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Sales | 272.5 | 258.6 | 281.7 | 286.7 | 266.7 |
| Expenses | 226.1 | 219.1 | 235.3 | 234.8 | 227.1 |
| Operating Profit | 46.4 | 39.5 | 46.4 | 51.9 | 39.6 |
| OPM % | 17.03% | 15.27% | 16.47% | 18.1% | 14.85% |
| Other Income | 23.1 | 13.7 | 22.4 | 22.3 | 35.2 |
| Interest | 1.5 | 1.5 | 1.6 | 1.6 | 1.5 |
| Depreciation | 7.6 | 6.6 | 6.2 | 6.5 | 6.9 |
| Profit before tax | 60.4 | 45.1 | 61.0 | 66.1 | 66.4 |
| Tax % | -19% | 27.7% | 26.6% | 24.5% | -18.4% |
| Net Profit | 48.9 | 32.6 | 44.8 | 49.9 | 54.2 |
| EPS in Rs | 2.19 | 1.39 | 1.86 | 2.07 | 0 |
| Metrics | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|
| Sales | 673.0 | 676.5 | 686.8 | 720.4 | 755.6 | 760.8 |
| Expenses | 534.3 | 547.6 | 560.7 | 588.6 | 608.1 | 605.5 |
| Operating Profit | 138.7 | 128.9 | 126.1 | 131.8 | 147.5 | 155.3 |
| OPM % | 20.61% | 19.05% | 18.36% | 18.3% | 19.52% | 20.41% |
| Other Income | 25.6 | 22.5 | 21.4 | 37.7 | 25.6 | 22.1 |
| Interest | 12.3 | 11.7 | 4.0 | 3.2 | 3.1 | 3.7 |
| Depreciation | 18.5 | 20.1 | 19.4 | 20.0 | 20.7 | 21.6 |
| Profit before tax | 131.1 | 119.6 | 124.1 | 146.3 | 149.3 | 152.1 |
| Tax % | -29% | -26.7% | -26.1% | -25% | -21.2% | 23.5% |
| Net Profit | 94.8 | 87.7 | 91.7 | 109.7 | 117.6 | 116.4 |
| EPS in Rs | 4.24 | 3.76 | 3.8 | 4.55 | 0 | 4.82 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 27% |
| 3 Years: | 9% |
| TTM: | 5% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 25% |
| 3 Years: | 11% |
| TTM: | 46% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 14% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 35% |
| 3 Years: | 19% |
| TTM: | 10% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 67% |
| 3 Years: | 29% |
| TTM: | 21% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 14% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|